10 April 2015
XP Power Limited
("XP Power" or "the Group")
Trading Update
XP Power, one of the world's leading developers and manufacturers of critical
power control components to the electronics industry, is today issuing a
trading update for the quarter ended 31 March 2015.
Trading
Trading in the first quarter has been encouraging. Group revenues in the three
months to 31 March 2015 were £25.6 million (2014: £24.4 million) up 5% from
those achieved in the same period a year ago. In constant currency revenues
were the same as in the prior year. Whilst the weaker Euro has had a negative
impact this has been more than compensated for by the stronger US Dollar.
Order intake in the quarter was also strong at £27.9 million (2014: £26.9
million) up 4% on the same period in the prior year.
Financial Position
Net cash was £nil million at 31 March 2015 compared with £1.3 million at the
year end.
Dividend
A dividend for the first quarter of 13 pence per share, an 8% increase over the
prior year, will be paid on 9 July 2015 to shareholders on the register at 12
June 2015 (2014: 12 pence per share).
Outlook
The Group has made a good start to its financial year, with the positive
momentum in the order intake experienced in the second half of 2014 continuing
into the first quarter. We therefore maintain our guidance that we would expect
to grow revenues in line with expectations in 2015.
XP will issue its interim results for the six months to 30 June 2015 on 27 July
2015.
- Ends -
Enquiries:
XP Power
Duncan Penny, Chief Executive +44 (0)7776 178 018
Jonathan Rhodes, Finance Director +44 (0)118 976 5074
Citigate Dewe Rogerson +44 (0)20 7638 9571
Kevin Smith/Jos Bieneman
Note to editors
XP designs and manufactures power controllers, the essential hardware component
in every piece of electrical equipment that converts the power from the
electricity grid into the right form for the equipment to function.
XP typically designs in power control solutions into the end products of major
blue chip OEMs, with a focus on the industrial (circa 45% of sales), healthcare
(circa 30% sales) and technology (circa 25% of sales) sectors. Once designed
into a program, XP has a revenue annuity over the life cycle of the customer's
product which is typically 5 to 7 years depending on the industry sector.
XP has invested in research and development and its own manufacturing
facilities in China and Vietnam, to develop a range of tailored products based
on its own intellectual property that provide its customers with significantly
improved functionality and efficiency.
Headquartered in Singapore and listed on the Main Market of the London Stock
Exchange since 2000, XP serves a global blue chip customer base from 29
locations in Europe, North America and Asia.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.